SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-13-000485
Filing Date
2013-02-19
Accepted
2013-02-19 11:30:48
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_123112.htm 10-Q 711736
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 18796
3 CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 18992
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 8702
5 CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER ex32_2.htm EX-32.2 8614
  Complete submission text file 0001387131-13-000485.txt   3856354

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20121231.xml EX-101.INS 635334
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20121231.xsd EX-101.SCH 24946
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20121231_cal.xml EX-101.CAL 38662
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20121231_def.xml EX-101.DEF 67471
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20121231_lab.xml EX-101.LAB 187282
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20121231_pre.xml EX-101.PRE 136904
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-88480 | Film No.: 13622223
SIC: 2834 Pharmaceutical Preparations